Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 105

1.

A 6-Year Posttreatment Follow-up of Panic Disorder Patients: Treatment With Clonazepam Predicts Lower Recurrence Than Treatment With Paroxetine.

Freire RC, Amrein R, Mochcovitch MD, Dias GP, Machado S, Versiani M, Arias-Carrión O, Carta MG, Nardi AE.

J Clin Psychopharmacol. 2017 Aug;37(4):429-434. doi: 10.1097/JCP.0000000000000740.

PMID:
28609307
2.

Methodological considerations on push-out tests in Endodontics.

De-Deus G, Souza E, Versiani M.

Int Endod J. 2015 May;48(5):501-3. doi: 10.1111/iej.12445. No abstract available.

PMID:
25851123
3.

Correlates of insight into different symptom dimensions in obsessive-compulsive disorder.

Fontenelle JM, Harrison BJ, Santana L, Conceição do Rosário M, Versiani M, Fontenelle LF.

Ann Clin Psychiatry. 2013 Feb;25(1):11-6.

PMID:
23376865
4.

Group cognitive behavior therapy for bipolar disorder can improve the quality of life.

Costa RT, Cheniaux E, Rangé BP, Versiani M, Nardi AE.

Braz J Med Biol Res. 2012 Sep;45(9):862-8. Epub 2012 Jun 28.

5.

Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry.

Fountoulakis KN, Kasper S, Andreassen O, Blier P, Okasha A, Severus E, Versiani M, Tandon R, Möller HJ, Vieta E.

Eur Arch Psychiatry Clin Neurosci. 2012 Jun;262 Suppl 1:1-48. doi: 10.1007/s00406-012-0323-x. Review.

PMID:
22622948
6.

A randomized, naturalistic, parallel-group study for the long-term treatment of panic disorder with clonazepam or paroxetine.

Nardi AE, Freire RC, Mochcovitch MD, Amrein R, Levitan MN, King AL, Valença AM, Veras AB, Paes F, Sardinha A, Nascimento I, de-Melo-Neto VL, Dias GP, E Silva AC, Soares-Filho GL, da Costa RT, Mezzasalma MA, de Carvalho MR, de Cerqueira AC, Hallak JE, Crippa JA, Versiani M.

J Clin Psychopharmacol. 2012 Feb;32(1):120-6. doi: 10.1097/JCP.0b013e31823fe4bd. Erratum in: J Clin Psychopharmacol. 2012 Apr;32(2):206.

PMID:
22198456
7.

Executive summary of the report by the WPA section on pharmacopsychiatry on general and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders.

Baghai TC, Blier P, Baldwin DS, Bauer M, Goodwin GM, Fountoulakis KN, Kasper S, Leonard BE, Malt UF, Stein DJ, Versiani M, Möller HJ.

Eur Arch Psychiatry Clin Neurosci. 2012 Feb;262(1):13-22. doi: 10.1007/s00406-011-0274-7. Epub 2011 Nov 15.

PMID:
22083391
8.

General and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders: a report by the WPA section of pharmacopsychiatry.

Baghai TC, Blier P, Baldwin DS, Bauer M, Goodwin GM, Fountoulakis KN, Kasper S, Leonard BE, Malt UF, Stein D, Versiani M, Möller HJ; Section of Pharmacopsychiatry, World Psychiatric Association.

Eur Arch Psychiatry Clin Neurosci. 2011 Nov;261 Suppl 3:207-45. doi: 10.1007/s00406-011-0259-6.

PMID:
22033583
9.

The effectiveness of cognitive behavioral group therapy in treating bipolar disorder: a randomized controlled study.

Costa RT, Cheniaux E, Rosaes PA, Carvalho MR, Freire RC, Versiani M, Rangé BP, Nardi AE.

Braz J Psychiatry. 2011 Jun;33(2):144-9.

10.

Randomized, open naturalistic, acute treatment of panic disorder with clonazepam or paroxetine.

Nardi AE, Valença AM, Freire RC, Amrein R, Sardinha A, Levitan MN, Nascimento I, de-Melo-Neto VL, King AL, de O e Silva AC, Veras AB, Dias GP, Soares-Filho GL, da Costa RT, Mezzasalma MA, de Carvalho MR, de Cerqueira AC, Hallak JE, Crippa JA, Versiani M.

J Clin Psychopharmacol. 2011 Apr;31(2):259-61. doi: 10.1097/JCP.0b013e318210b4ee. No abstract available.

PMID:
21364347
11.

Psychopharmacotherapy of panic disorder: 8-week randomized trial with clonazepam and paroxetine.

Nardi AE, Valença AM, Freire RC, Mochcovitch MD, Amrein R, Sardinha A, Levitan MN, Nascimento I, de-Melo-Neto VL, King AL, de O E Silva AC, Veras AB, Dias GP, Soares-Filho GL, da Costa RT, Mezzasalma MA, de Carvalho MR, de Cerqueira AC, Hallak JE, Crippa JA, Versiani M.

Braz J Med Biol Res. 2011 Apr;44(4):366-73. Epub 2011 Feb 18.

12.

Second-generation antidepressants in social anxiety disorder: meta-analysis of controlled clinical trials.

de Menezes GB, Coutinho ES, Fontenelle LF, Vigne P, Figueira I, Versiani M.

Psychopharmacology (Berl). 2011 May;215(1):1-11. doi: 10.1007/s00213-010-2113-3. Epub 2010 Dec 22.

PMID:
21181129
13.

EEG frontal asymmetry in the depressed and remitted elderly: is it related to the trait or to the state of depression?

Carvalho A, Moraes H, Silveira H, Ribeiro P, Piedade RA, Deslandes AC, Laks J, Versiani M.

J Affect Disord. 2011 Mar;129(1-3):143-8. doi: 10.1016/j.jad.2010.08.023. Epub 2010 Sep 25.

PMID:
20870292
14.

Efficacy and safety of electroconvulsive therapy in the treatment of bipolar disorder: a systematic review.

Versiani M, Cheniaux E, Landeira-Fernandez J.

J ECT. 2011 Jun;27(2):153-64. doi: 10.1097/YCT.0b013e3181e6332e. Review.

PMID:
20562714
15.

Quality of life and symptom dimensions of patients with obsessive-compulsive disorder.

Fontenelle IS, Fontenelle LF, Borges MC, Prazeres AM, Rangé BP, Mendlowicz MV, Versiani M.

Psychiatry Res. 2010 Sep 30;179(2):198-203. doi: 10.1016/j.psychres.2009.04.005. Epub 2010 May 18.

PMID:
20483484
16.

Tapering clonazepam in patients with panic disorder after at least 3 years of treatment.

Nardi AE, Freire RC, Valença AM, Amrein R, de Cerqueira AC, Lopes FL, Nascimento I, Mezzasalma MA, Veras AB, Sardinha A, de Carvalho MR, da Costa RT, Levitan MN, de-Melo-Neto VL, Soares-Filho GL, Versiani M.

J Clin Psychopharmacol. 2010 Jun;30(3):290-3. doi: 10.1097/JCP.0b013e3181dcb2f3.

PMID:
20473065
17.

The Brazilian Portuguese version of the Saving Inventory-Revised: internal consistency, test-retest reliability, and validity of a questionnaire to assess hoarding.

Fontenelle IS, Prazeres AM, Borges MC, Rangé BP, Versiani M, Fontenelle LF.

Psychol Rep. 2010 Feb;106(1):279-96.

PMID:
20402454
18.

Predictors of adherence among patients with obsessive-compulsive disorder undergoing naturalistic pharmacotherapy.

Santana L, Versiani M, Mendlowicz MV, Fontenelle LF.

J Clin Psychopharmacol. 2010 Feb;30(1):86-8. doi: 10.1097/JCP.0b013e3181c8272a. No abstract available.

PMID:
20075661
19.

Double-blind comparison of 30 and 60 mg tranylcypromine daily in patients with panic disorder comorbid with social anxiety disorder.

Nardi AE, Lopes FL, Valença AM, Freire RC, Nascimento I, Veras AB, Mezzasalma MA, de-Melo-Neto VL, Soares-Filho GL, King AL, Grivet LO, Rassi A, Versiani M.

Psychiatry Res. 2010 Feb 28;175(3):260-5. doi: 10.1016/j.psychres.2008.06.025. Epub 2009 Dec 29.

PMID:
20036427
20.

The diagnoses of schizophrenia, schizoaffective disorder, bipolar disorder and unipolar depression: interrater reliability and congruence between DSM-IV and ICD-10.

Cheniaux E, Landeira-Fernandez J, Versiani M.

Psychopathology. 2009;42(5):293-8. doi: 10.1159/000228838. Epub 2009 Jul 16.

PMID:
19609099

Supplemental Content

Loading ...
Support Center